Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001207017-14-000089
Filing Date
2014-11-07
Accepted
2014-11-07 16:37:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 r13gphibroanimal.htm SC 13G/A 4492
  Complete submission text file 0001207017-14-000089.txt   6166
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-88114 | Film No.: 141205377
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 ROCKEFELLER PLZ 55TH FL. NEW YORK NY 10112
Business Address 30 ROCKEFELLER PLZ 55TH FL. NEW YORK NY 10112 2126321890
LAZARD ASSET MANAGEMENT LLC (Filed by) CIK: 0001207017 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13G/A